🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 6 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/08/1999 | 59,16 | 59,76 | 58,33 | 59,40 | +0,30% | 2,42% | 5.366.284 |
| 09/08/1999 | 60,11 | 60,35 | 59,16 | 59,22 | -0,40% | 1,98% | 5.253.938 |
| 06/08/1999 | 60,29 | 60,65 | 59,04 | 59,46 | -2,64% | 2,67% | 6.491.522 |
| 05/08/1999 | 61,19 | 61,43 | 59,58 | 61,07 | -0,78% | 3,02% | 8.355.914 |
| 04/08/1999 | 63,87 | 63,99 | 60,59 | 61,55 | -3,73% | 5,32% | 8.408.733 |
| 03/08/1999 | 64,71 | 65,00 | 63,57 | 63,93 | -0,56% | 2,21% | 3.936.288 |
| 02/08/1999 | 64,17 | 65,54 | 64,05 | 64,29 | -0,37% | 2,32% | 3.458.295 |
| 30/07/1999 | 64,89 | 65,42 | 64,47 | 64,53 | +1,31% | 1,47% | 4.474.750 |
| 29/07/1999 | 63,93 | 64,35 | 63,22 | 63,69 | -2,55% | 1,77% | 4.670.517 |
| 28/07/1999 | 65,12 | 65,60 | 64,65 | 65,36 | -0,36% | 1,47% | 3.469.090 |
| 27/07/1999 | 65,84 | 66,20 | 65,24 | 65,60 | +0,64% | 1,45% | 4.084.161 |
| 26/07/1999 | 65,48 | 65,96 | 64,95 | 65,18 | -1,00% | 1,55% | 4.602.292 |
| 23/07/1999 | 65,60 | 66,91 | 65,12 | 65,84 | -0,54% | 2,73% | 4.584.895 |
| 22/07/1999 | 65,42 | 66,56 | 65,42 | 66,20 | +1,00% | 1,73% | 4.404.744 |
| 21/07/1999 | 65,42 | 66,32 | 65,18 | 65,54 | +0,00% | 1,73% | 5.647.462 |
| 20/07/1999 | 66,85 | 67,21 | 65,12 | 65,54 | -2,74% | 3,12% | 4.780.976 |
| 19/07/1999 | 68,11 | 68,46 | 66,97 | 67,39 | -0,70% | 2,19% | 4.015.412 |
| 16/07/1999 | 68,23 | 69,06 | 67,39 | 67,87 | -2,57% | 2,45% | 7.559.014 |
| 15/07/1999 | 69,66 | 70,61 | 68,88 | 69,66 | +0,34% | 2,48% | 4.004.094 |
| 14/07/1999 | 71,33 | 71,39 | 69,36 | 69,42 | -2,51% | 2,84% | 4.143.897 |
| 13/07/1999 | 70,97 | 71,51 | 70,85 | 71,21 | -0,50% | 0,92% | 3.655.424 |
| 12/07/1999 | 72,40 | 72,40 | 70,49 | 71,56 | -0,25% | 2,64% | 3.031.026 |
| 09/07/1999 | 72,34 | 72,34 | 71,56 | 71,74 | -0,17% | 1,07% | 2.697.762 |
| 08/07/1999 | 70,49 | 72,34 | 70,25 | 71,86 | +0,84% | 2,96% | 3.802.249 |
| 07/07/1999 | 70,25 | 71,33 | 70,13 | 71,27 | +1,01% | 1,70% | 3.256.136 |
| 06/07/1999 | 71,45 | 71,98 | 70,13 | 70,55 | -1,74% | 2,59% | 4.158.359 |
| 02/07/1999 | 72,04 | 72,46 | 71,09 | 71,80 | +0,00% | 1,90% | 3.645.678 |
| 01/07/1999 | 70,49 | 72,16 | 69,90 | 71,80 | +2,21% | 3,22% | 6.230.989 |
| 30/06/1999 | 68,58 | 70,61 | 67,45 | 70,25 | +2,97% | 4,61% | 6.905.377 |
| 29/06/1999 | 66,79 | 68,70 | 66,62 | 68,23 | +2,05% | 3,12% | 5.944.780 |